Autonomix Medical - רווח נקי למניה אחת בשנים עשר החודשים האחרונים AMIX

The implementation of eco-polymers and waste reduction efforts are driving the growth of Autonomix Medical, Inc. (AMIX). This daily price chart of the rolling annual EPS YoY from GURU.Markets demonstrates the impact of these ESG factors, where 81.70 serves as the current metric level. Business resilience is supported by diversified electronics sourcing, while market positions are strengthened by proprietary microsensors for oncology pain therapy.

This indicator measures the relative change in net income per share over twelve months, reflecting profit generation efficiency compared to market peers. It allows investors to assess the impact of operating expenses on the business's bottom-line profitability. By analyzing the annual growth rate of EPS (TTM), one can identify the sustainability of returns. For Autonomix Medical, Inc. (AMIX), this confirms the monetization of clinic loyalty toward consumables. Stable demand for disposable catheters ensures high margins.